MedTrace Logo

Nasopharyngeal Carriage Study in Healthy Kenyan Toddlers

NCT02146365 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 297

Last updated 2020-02-17

Study results available
· View outcomes & findings →

Summary

This study evaluated the change in nasopharyngeal carriage (NPC) of Streptococcus pneumoniae (SPn), hypothesizing that it would be reduced post-vaccination with Streptococcus pneumoniae whole cell vaccine with aluminum hydroxide adjuvant (PATH-wSP) and that PATH-wSP would remain safe and well-tolerated over the course of the study.

Conditions

  • Pneumococcal Disease

Sponsors & Collaborators

  • PATH

    lead OTHER

Principal Investigators

  • Nekoye Otsyula, MB ChB MSc · Kenya Medical Research Institute/Walter Reed Project

Eligibility

Min Age
12 Months
Max Age
15 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-25
Primary Completion
2016-02-18
Completion
2016-02-18

Countries

  • Kenya

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02146365 on ClinicalTrials.gov